110.77 -0.00 (-0.00%)
After hours: 4:16PM EDT
|Bid||110.21 x 800|
|Ask||115.00 x 1100|
|Day's range||109.05 - 110.82|
|52-week range||88.00 - 119.44|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||28.04|
|Earnings date||03 Aug 2020 - 07 Aug 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||96.22|
An earnings release is available on the Company's website. Today, you will hear from China Biologic's Chairman and CEO, Mr. Joseph Chow, who will start off the call with a review of the Company's basic operating results and report recent developments for the Company. China Biologic's CFO, Mr. Ming Yang, will be available during the Q&A session following the prepared remarks.
China's Centurium Capital, a big backer of domestic startup Luckin Coffee, said it has raised more than $2 billion in its debut fund, giving the private equity firm more firepower to cut deals involving the world's second-largest economy. The firm, co-founded by the former head of Warburg Pincus Asia Pacific, David Li, said in a statement on Wednesday that Centurium Capital Partners 2018 L.P. raised the sum in U.S. dollars. The fund secured strong interest from global investors, known as limited partners (LPs), such as pension funds, sovereign wealth funds and funds-of-funds, it said.